1Benoist S, Nordlinger B. Neoadjuvant treatment before resection of liver metastases [ J]. Eur J Surg Oncol, 2007, 33 ( Suppl 2) : S35 - S41.
2Adam R, Pascal G, Castaing D, et al. Tumor progression while on chemotherapy : a contraindication to liver resection for multiple colorectal metastases? [J]. Ann Surg, 2004, 240(6):1052-1061.
3Nordlinger B, Sorbye H, Collette L, et al. Final results of the EORTC Intergroup randomized phase Ⅲ study 40983 [ EPOC ] evaluating the benefit of peri-operative FOLFOX4 chemotherapy for patients with potentially resectable colorectal cancer liver metastases [ J ]. J Clin Oncol, 2007, 25(18s) : LBA5.
4Adam R, Delvart V, Pascal G, et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival[J]. Ann Surg, 2004, 240(4): 644-657.
5Pozzo C, Barone C, Kemeny N E. Advances in neoadjuvant therapy for colorectal cancer with liver metastases [ J ]. Cancer Treat Rev, 2008, 34(4) : 293 -301.
6Charnsangavej C, Clary B, Fong Y, et al. Selection of patients for resection of hepatic colorectal metastases: expert consensus statement [J]. Ann Surg Oncol, 2006, 13(10) : 1261 -1268.
7Dy G K, Krook J E, Green E M, et al. Impact of complete response to chemotherapy on overall survival in advanced colorectal cancer: results from intergroup N9741 [ J ]. J Clin Oncol, 2007, 25 ( 23 ) : 3469 - 3474.
8Alberts S R, Horvath W L, Sternfeld W C, et al. Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: a North Central Cancer Treatment Group phase Ⅱ study[ J]. J Clin Oncol, 2005, 23 (36) : 9243 - 9249.
9Nordlinger B, Van-Custem E, Rougier P, et al. Does chemotherapy prior to liver resection increase the potential for cure in patients with metastatic colorectal cancer? A report from the European Colorectal Metastases Treatment Gwup[J]. Eur J Cancer, 2007, 43(14): 2037-2045.
10I-Iurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer[J]. N Engl J Med, 2004, 350(23) : 2335 -2342.
同被引文献17
1Janja Ocvirk,Thomas Brodowicz,Fritz Wrba,Tudor E Ciuleanu,Galina Kurteva,Semir Beslija,Ivan Koza,Zsuzsanna Pápai,Diethelm Messinger,Ugur Yilmaz,Zsolt Faluhelyi,Suayib Yalcin,Demetris Papamichael,Miklós Wenczl,Zrinka Mrsic-Krmpotic,Einat Shacham-Shmueli,Damir Vrbanec,Regina Esser,Werner Scheithauer,Christoph C Zie-linski.Cetuximab plus FOLFOX6 or FOLFIRI in metastatic colorectal cancer: CECOG trial[J].World Journal of Gastroenterology,2010,16(25):3133-3143. 被引量：18
2Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fluorouracil and leucovofin for metastatic colorectal cancer. N Engl J Med,2004,350(23) :2335-2342.
3Wieheas D A, de-Haas R J, Adam R. Bringing unreseetable liver disease to resection with curative intent. Eur J Surg Oneol,2007,33 ( Suppl 2) :S42-S51.
